£107.98

Springer Non-coding RNAs in Colorectal Cancer: 937 (Advances in Experimental Medicine and Biology, 937)

Price data checked 1 day ago

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£108 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 90 days • 90 data points

Historical
Generating forecast...
£109.96 £107.78 £108.26 £108.73 £109.21 £109.68 £110.16 18 February 2026 12 March 2026 03 April 2026 25 April 2026 18 May 2026

Price Distribution

Price distribution over 90 days • 2 price levels

Days at Price
Current Price
5 days · current 85 days 0 21 43 64 85 £108 £110 Days at Price

Price Analysis

Most common price: £110 (85 days, 94.4%)

Price range: £108 - £110

Price levels: 2 different prices over 90 days

Description

This is the first book to provide a broad framework for obtaining an in depth understanding of the state-of-the-art knowledge on abnormalities of non-coding RNAs found to be associated with colorectal cancer pathogenesis. Readers will discover possible mechanisms underlying the substantial roles played by non-coding RNAs in molecular hallmarks of colorectal cancer. This work further provides the comprehensive overview and novel insights into using of non-coding RNAs as colorectal cancer biomarkers enabling early detection of the disease, prognostic stratification of the patients and prediction of therapeutic response. The reader is introduced to the overview of modern non-coding RNAs-based therapeutic strategies, and summary of their preclinical testing performed in colorectal cancer. The work is written for researchers who want to explore current state of the knowledge in this interesting field of molecular oncology.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Molecular Pathogenesis of Colorectal Cancer
89% match

Molecular Pathogenesis of Colorectal Cancer

Springer

£110.54 18 May 2026
Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)
87% match

Molecular Genetics of Colorectal Neoplasia: A Primer for the Clinician: 82 (Developments in Oncology)

Springer

£85.52 18 May 2026
Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications
85% match

Hereditary Colorectal Cancer: Genetic Basis and Clinical Implications

Springer

£136.92 18 May 2026
Genetics of Colorectal Cancer (Cancer Genetics)
85% match

Genetics of Colorectal Cancer (Cancer Genetics)

Springer

£107.98 18 May 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
84% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£80.64 17 May 2026
Management of Colorectal Cancers in Older People
83% match

Management of Colorectal Cancers in Older People

Springer

£80.64 17 May 2026
Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)
83% match

Metabolism in Cancer: 207 (Recent Results in Cancer Research, 207)

Springer

£73.10 18 May 2026
Gene Regulation and Therapeutics for Cancer
82% match

Gene Regulation and Therapeutics for Cancer

CRC Press

£69.94 11 May 2026
Colorectal Cancer: Prevention, Diagnosis and Treatment
82% match

Colorectal Cancer: Prevention, Diagnosis and Treatment

£55.55 18 May 2026
Cancer Genetics and Therapeutics: Focus on Phytochemicals
82% match

Cancer Genetics and Therapeutics: Focus on Phytochemicals

Springer

£74.27 18 May 2026
DNA Repair of Cancer Stem Cells
82% match

DNA Repair of Cancer Stem Cells

Springer

£108.75 11 May 2026
Gene-Based Therapies for Cancer (Current Cancer Research)
82% match

Gene-Based Therapies for Cancer (Current Cancer Research)

Springer

£107.50 18 May 2026
Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)
82% match

Male Reproductive Cancers: Epidemiology, Pathology and Genetics (Cancer Genetics)

Springer

£141.83 18 May 2026
DNA Methylation and Cancer Therapy (Medical Intelligence Unit)
82% match

DNA Methylation and Cancer Therapy (Medical Intelligence Unit)

Springer

£107.98 18 May 2026
MicroRNA Cancer Regulation: Advanced Concepts, Bioinformatics and Systems Biology Tools: 774 (Advances in Experimental Medicine and Biology, 774)
82% match

MicroRNA Cancer Regulation: Advanced Concepts, Bioinformatics and Systems Biology Tools: 774 (Advances in Experimental Medicine and Biology, 774)

Springer

£107.98 18 May 2026
Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)
82% match

Modern Molecular Biology:: Approaches for Unbiased Discovery in Cancer Research (Applied Bioinformatics and Biostatistics in Cancer Research)

Springer

£107.30 18 May 2026
Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)
81% match

Colorectal Cancer: Evidence-based Chemotherapy Strategies (Current Clinical Oncology)

Humana

£40.30 04 May 2026
Advances in Endophytic Research
81% match

Advances in Endophytic Research

Springer

£146.73 18 May 2026
Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy
81% match

Regulation of Carcinogenesis, Angiogenesis and Metastasis by the Proprotein Convertases (PC's): A New Potential Strategy in Cancer Therapy

Springer

£113.76 18 May 2026
Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)
81% match

Rectal Cancer: International Perspectives on Multimodality Management (Current Clinical Oncology)

Humana

£80.64 17 May 2026
Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)
81% match

Risk and Progression Factors in Carcinogenesis: 143 (Recent Results in Cancer Research, 143)

Springer

£77.79 11 May 2026
Prognostic variables in node-negative and node-positive breast cancer
81% match

Prognostic variables in node-negative and node-positive breast cancer

Springer

£171.81 18 May 2026
Cancer Biomarkers in Body Fluids: Biomarkers in Circulation
81% match

Cancer Biomarkers in Body Fluids: Biomarkers in Circulation

Springer

£146.27 18 May 2026
Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)
81% match

Causes and Control of Colorectal Cancer: A Model for Cancer Prevention: 78 (Developments in Oncology, 78)

Springer

£149.38 18 May 2026